Physiologically Based Pharmacokinetic Modeling (PDF)
Science and Applications
(Sprache: Englisch)
A definitive, single source of information on PBPK modeling
Physiologically-based pharmacokinetic (PBPK) modeling is becoming
increasingly important in human health risk assessments and in
supporting pharmacodynamic modeling for toxic responses....
Physiologically-based pharmacokinetic (PBPK) modeling is becoming
increasingly important in human health risk assessments and in
supporting pharmacodynamic modeling for toxic responses....
sofort als Download lieferbar
eBook (pdf)
Fr. 155.00
inkl. MwSt.
- Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Physiologically Based Pharmacokinetic Modeling (PDF)“
A definitive, single source of information on PBPK modeling
Physiologically-based pharmacokinetic (PBPK) modeling is becoming
increasingly important in human health risk assessments and in
supporting pharmacodynamic modeling for toxic responses. Organized
by classes of compounds and modeling purposes so users can quickly
access information, this is the first comprehensive reference of
its kind.
This book presents an overview of the underlying principles of PBPK
model development. Then it provides a compendium of PBPK modeling
information, including historical development, specific modeling
challenges, and current practices for:
* Halogenated Alkanes
* Halogenated Alkenes
* Alkene and Aromatic Compounds
* Reactive Vapors in the Nasal Cavity
* Alkanes, Oxyhydrocarbons, and Related Compounds
* Pesticides and Persistent Organic Pollutants
* Dioxin and Related Compounds
* Metals and Inorganic Compounds
* Drugs
* Antineoplastic Agents
* Perinatal Transfer
* Mixtures
* Dermal Exposure Models
In addition to pinpointing specific information, readers can
explore diverse modeling techniques and applications. An
authoritative reference for toxicologists, ecotoxicologists, risk
assessors, regulators, pharmacologists, pharmacists, and graduate
students in pharmacokinetics and toxicology, Physiologically-Based
Pharmacokinetic Modeling compiles information from leaders in the
field and discusses future directions for PBPK modeling.
Physiologically-based pharmacokinetic (PBPK) modeling is becoming
increasingly important in human health risk assessments and in
supporting pharmacodynamic modeling for toxic responses. Organized
by classes of compounds and modeling purposes so users can quickly
access information, this is the first comprehensive reference of
its kind.
This book presents an overview of the underlying principles of PBPK
model development. Then it provides a compendium of PBPK modeling
information, including historical development, specific modeling
challenges, and current practices for:
* Halogenated Alkanes
* Halogenated Alkenes
* Alkene and Aromatic Compounds
* Reactive Vapors in the Nasal Cavity
* Alkanes, Oxyhydrocarbons, and Related Compounds
* Pesticides and Persistent Organic Pollutants
* Dioxin and Related Compounds
* Metals and Inorganic Compounds
* Drugs
* Antineoplastic Agents
* Perinatal Transfer
* Mixtures
* Dermal Exposure Models
In addition to pinpointing specific information, readers can
explore diverse modeling techniques and applications. An
authoritative reference for toxicologists, ecotoxicologists, risk
assessors, regulators, pharmacologists, pharmacists, and graduate
students in pharmacokinetics and toxicology, Physiologically-Based
Pharmacokinetic Modeling compiles information from leaders in the
field and discusses future directions for PBPK modeling.
Autoren-Porträt von Micaela Reddy, R. S. Yang, Melvin E. Andersen, Iii Clewell
The EDITORS have worked together on PBPK research and in teachingPBPK modeling workshops and courses through the Quantitative and
Computation Toxicology research group at the Center for
Environ-mental Toxicology and Technology (CETT) in the Department
of Environmental and Radiological Health Sciences at Colorado State
University (CSU).
MICAELA B. REDDY, PhD, is a research professor at CETT where she
has developed PBPK models for risk assessment and toxicology
applications.
RAYMOND S. H. YANG, PhD, Professor of Toxicology and former
director, CETT, championed applications of PBPK modeling in
research on the toxicology of chemical mixtures.
HARVEY J. CLEWELL III, MS, Director, Center for Human Health
Assessment, CIIT Centers for Health Research, Research Triangle
Park, North Carolina, played a major role in the first uses of PBPK
modeling in cancer and non-cancer risk assessments by several
federal agencies, including EPA, ATSDR, OSHA, and FDA.
MELVIN E. ANDERSEN, PhD, a pioneer in use of PBPK modeling in
toxicology and risk assessment, is Director, Computational Biology
Division, CIIT Centers for Health Research, Research Triangle Park,
North Carolina.
Bibliographische Angaben
- Autoren: Micaela Reddy , R. S. Yang , Melvin E. Andersen , Iii Clewell
- 2005, 1. Auflage, 440 Seiten, Englisch
- Verlag: John Wiley & Sons
- ISBN-10: 0471478776
- ISBN-13: 9780471478775
- Erscheinungsdatum: 31.05.2005
Abhängig von Bildschirmgrösse und eingestellter Schriftgrösse kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Grösse: 3.25 MB
- Mit Kopierschutz
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "Physiologically Based Pharmacokinetic Modeling"
0 Gebrauchte Artikel zu „Physiologically Based Pharmacokinetic Modeling“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Physiologically Based Pharmacokinetic Modeling".
Kommentar verfassen